Yurvac RHD RSS Authorised This medicine is authorised for use in the European Union rabbit haemorrhagic disease virus, capsid protein antigen, recombinant Medicine Veterinary Authorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on Yurvac RHD Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine Yurvac RHD Active substance rabbit haemorrhagic disease virus, capsid protein antigen, recombinant International non-proprietary name (INN) or common name rabbit haemorrhagic disease virus, capsid protein antigen, recombinant Pharmacotherapeutic groupImmunologicals for leporidaeOther inactivated vaccines Authorisation details EMA product number EMEA/V/C/005992 Assessment history Expand section Collapse section Changes since initial authorisation of medicine CVMP post-authorisation summary of positive opinion for Yurvac (VRA-0001)Adopted Reference Number: EMA/CVMP/433078/2024 English (EN) (143.29 KB - PDF)First published: 20/09/2024 View Initial marketing authorisation documents CVMP summary of positive opinion for YURVAC RHDAdopted Reference Number: EMA/CVMP/311987/2023 English (EN) (118.27 KB - PDF)First published: 14/07/2023 View News on Yurvac RHD Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 October 202510/10/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 September 202413/09/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 July 202314/07/2023 This page was last updated on 11/03/2024 Share this page